Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Lysergic acid diethylamide by Mind Medicine MindMed for Generalized Anxiety Disorder (GAD): Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Generalized Anxiety Disorder...
Lysergic acid diethylamide by Mind Medicine MindMed for Major Depressive Disorder: Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder....
Lysergic acid diethylamide by Mind Medicine MindMed for Generalized Anxiety Disorder (GAD): Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Generalized Anxiety Disorder...
Lysergic acid diethylamide by Mind Medicine MindMed for Major Depressive Disorder: Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder....
Lysergic acid diethylamide by Mind Medicine MindMed for Cluster Headache Syndrome (Cluster Headache): Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Cluster Headache Syndrome...
MM-402 by Mind Medicine MindMed for Autism Spectrum Disorder (ASD): Likelihood of Approval
MM-402 is under clinical development by Mind Medicine MindMed and currently in Phase I for Autism Spectrum Disorder (ASD). According...
Risk adjusted net present value: What is the current valuation of Mind Medicine MindMed's Lysergic Acid Diethylamide?
Lysergic Acid Diethylamide is a small molecule commercialized by Mind Medicine MindMed, with a leading Phase II program in Major...